REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 141 filers reported holding REVOLUTION MEDICINES INC in Q2 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $38,711,229 | +20.4% | 997,455 | 0.0% | 1.81% | +33.6% |
| Q1 2024 | $32,147,975 | +12.4% | 997,455 | 0.0% | 1.36% | -11.4% |
| Q4 2023 | $28,607,009 | +3.6% | 997,455 | 0.0% | 1.53% | -16.6% |
| Q3 2023 | $27,609,554 | +20.8% | 997,455 | +16.7% | 1.83% | +34.4% |
| Q2 2023 | $22,857,447 | +23.5% | 854,484 | 0.0% | 1.36% | +1.9% |
| Q1 2023 | $18,508,123 | – | 854,484 | – | 1.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 5,104,130 | $99,479,000 | 40.69% |
| Ponoi II Management, LLC | 685,011 | $13,351,000 | 36.28% |
| Nextech Invest Ltd. | 3,939,529 | $76,781,000 | 25.90% |
| Ponoi Management, LLC | 685,011 | $13,351,000 | 21.08% |
| Column Group LLC | 4,395,050 | $85,660,000 | 18.23% |
| TRV GP IV, LLC | 1,419,900 | $27,674,000 | 18.20% |
| Boxer Capital, LLC | 3,484,264 | $67,908,000 | 4.30% |
| Casdin Capital, LLC | 2,370,000 | $46,191,000 | 3.91% |
| Cormorant Asset Management, LP | 1,995,066 | $38,884,000 | 2.94% |
| EcoR1 Capital, LLC | 4,278,069 | $83,380,000 | 2.88% |